STOCK TITAN
  1. Home
  2. Sec-filings
  3. RCKT
  4. [EFFECT] ROCKET PHARMACEUTICALS, INC. SEC Filing

[EFFECT] ROCKET PHARMACEUTICALS, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 10, 2026 4:00 P.M.
Form: S-3
CIK: 0001281895
Company Name: ROCKET PHARMACEUTICALS, INC.
File Number: 333-293925

Source: View Original Filing on SEC EDGAR

Rocket Pharmaceu

NASDAQ:RCKT

View RCKT Stock Overview →

RCKT Rankings

#3391 Ranked by Market Cap
N/A Ranked by Dividends

RCKT Latest News

Feb 26, 2026
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
Feb 23, 2026
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Jan 5, 2026
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Nov 25, 2025
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
Nov 6, 2025
Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

RCKT Latest SEC Filings

Mar 10, 2026
[8-K] ROCKET PHARMACEUTICALS, INC. Reports Material Event
Mar 10, 2026
[424B5] ROCKET PHARMACEUTICALS, INC. Prospectus Supplement (Debt Securities)
Mar 2, 2026
[S-3] ROCKET PHARMACEUTICALS, INC. Shelf Registration Statement
Feb 26, 2026
[8-K] ROCKET PHARMACEUTICALS, INC. Reports Material Event
Feb 26, 2026
[10-K] ROCKET PHARMACEUTICALS, INC. Files Annual Report

RCKT Stock Data

534.16M
103.51M
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK